Perfil
Jean Jacques Mention is currently the Chief Business Officer at OSE Immunotherapeutics SA. Prior to this, he held positions as Director of Business Development at Axenis SAS and Head of Business Development at genOway SA.
Cargos activos de Jean Jacques Mention
| Empresas | Cargo | Inicio |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Jean Jacques Mention.
| Empresas | Cargo | Fin |
|---|---|---|
| GENOWAY | Corporate Officer/Principal | - |
Axenis SAS
 Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The private company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GENOWAY | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Empresas privadas | 1 |
|---|---|
Axenis SAS
Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The private company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million. | Health Technology |
- Bolsa de valores
- Insiders
- Jean Jacques Mention
